FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
15 02 2019
Historique:
received: 12 09 2018
accepted: 16 10 2018
pubmed: 26 10 2018
medline: 22 6 2019
entrez: 26 10 2018
Statut: ppublish

Résumé

Huntington's disease (HD) is an inherited neurodegenerative disease caused by an expanded CAG repeat in the huntingtin (HTT) gene. CAG repeat length explains around half of the variation in age at onset (AAO) but genetic variation elsewhere in the genome accounts for a significant proportion of the remainder. Genome-wide association studies have identified a bidirectional signal on chromosome 15, likely underlain by FANCD2- and FANCI-associated nuclease 1 (FAN1), a nuclease involved in DNA interstrand cross link repair. Here we show that increased FAN1 expression is significantly associated with delayed AAO and slower progression of HD, suggesting FAN1 is protective in the context of an expanded HTT CAG repeat. FAN1 overexpression in human cells reduces CAG repeat expansion in exogenously expressed mutant HTT exon 1, and in patient-derived stem cells and differentiated medium spiny neurons, FAN1 knockdown increases CAG repeat expansion. The stabilizing effects are FAN1 concentration and CAG repeat length-dependent. We show that FAN1 binds to the expanded HTT CAG repeat DNA and its nuclease activity is not required for protection against CAG repeat expansion. These data shed new mechanistic insights into how the genetic modifiers of HD act to alter disease progression and show that FAN1 affects somatic expansion of the CAG repeat through a nuclease-independent mechanism. This provides new avenues for therapeutic interventions in HD and potentially other triplet repeat disorders.

Identifiants

pubmed: 30358836
pii: 5144444
doi: 10.1093/hmg/ddy375
pmc: PMC6360275
doi:

Substances chimiques

HTT protein, human 0
Huntingtin Protein 0
Multifunctional Enzymes 0
Endodeoxyribonucleases EC 3.1.-
Exodeoxyribonucleases EC 3.1.-
FAN1 protein, human EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

650-661

Subventions

Organisme : Medical Research Council
ID : MR/L02053X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L010305/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 200181/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M02492X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_14108
Pays : United Kingdom

Références

Hum Mol Genet. 2015 Dec 15;24(24):7087-96
pubmed: 26420841
Hum Mol Genet. 2003 Dec 15;12(24):3359-67
pubmed: 14570710
Hum Mol Genet. 2015 Jun 1;24(11):3257-71
pubmed: 25740845
PLoS Comput Biol. 2007 Nov;3(11):e235
pubmed: 18039028
Mov Disord. 2014 Sep 15;29(11):1359-65
pubmed: 25154728
Mol Cell Biol. 2014 Nov;34(21):3939-54
pubmed: 25135477
Nat Commun. 2011;2:281
pubmed: 21505437
Brain. 2014 Mar;137(Pt 3):819-33
pubmed: 24459107
Genes Dev. 2016 Mar 15;30(6):639-44
pubmed: 26980188
Science. 2010 Aug 6;329(5992):693-6
pubmed: 20671156
PLoS One. 2014 Oct 10;9(10):e109752
pubmed: 25303670
Hum Mol Genet. 2017 Oct 1;26(19):3859-3867
pubmed: 28934397
Ann Neurol. 2016 Jun;79(6):983-90
pubmed: 27044000
Hum Mol Genet. 2000 Oct 12;9(17):2539-44
pubmed: 11030759
Cell. 1995 May 19;81(4):533-40
pubmed: 7758107
DNA Repair (Amst). 2014 Sep;21:55-64
pubmed: 25037770
Hum Mol Genet. 2009 Aug 15;18(16):3039-47
pubmed: 19465745
Cell. 2015 Jul 30;162(3):516-26
pubmed: 26232222
Nat Genet. 2016 Mar;48(3):245-52
pubmed: 26854917
Cell. 2010 Jul 9;142(1):77-88
pubmed: 20603016
Nat Rev Genet. 2005 Oct;6(10):729-42
pubmed: 16205713
Lancet Neurol. 2017 Sep;16(9):701-711
pubmed: 28642124
PLoS Genet. 2013 Oct;9(10):e1003930
pubmed: 24204323
Genes Dev. 2016 Mar 15;30(6):645-59
pubmed: 26980189
Lancet Neurol. 2013 Jul;12(7):637-49
pubmed: 23664844
EMBO J. 2014 Aug 1;33(15):1698-712
pubmed: 24966277
Science. 2016 Feb 19;351(6275):846-9
pubmed: 26797144
PLoS Genet. 2013;9(2):e1003280
pubmed: 23468640
Mol Cell. 2010 Jul 9;39(1):36-47
pubmed: 20603073
Cell. 2010 Jul 9;142(1):65-76
pubmed: 20603015
DNA Repair (Amst). 2016 Feb;38:117-126
pubmed: 26774442
Cell. 1993 Mar 26;72(6):971-83
pubmed: 8458085
Nat Genet. 2012 Jul 08;44(8):910-5
pubmed: 22772369
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Development. 2015 Apr 1;142(7):1375-86
pubmed: 25804741
DNA Repair (Amst). 2017 Aug;56:135-143
pubmed: 28623094
Nat Rev Dis Primers. 2015 Apr 23;1:15005
pubmed: 27188817
Nat Commun. 2017 Oct 20;8(1):1073
pubmed: 29051491
Nucleic Acids Res. 2009 Jul;37(13):4420-9
pubmed: 19468048
DNA Repair (Amst). 2018 Sep;69:1-5
pubmed: 29990673
Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):397-408
pubmed: 19548255
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503
pubmed: 14993615
Nat Rev Genet. 2010 Nov;11(11):786-99
pubmed: 20953213

Auteurs

Robert Goold (R)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Michael Flower (M)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Davina Hensman Moss (DH)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Chris Medway (C)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, CF24 4HQ, UK.

Alison Wood-Kaczmar (A)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Ralph Andre (R)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Pamela Farshim (P)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.

Gill P Bates (GP)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.
UK Dementia Research Institute, University College London, WC1N 3BG, UK.

Peter Holmans (P)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, CF24 4HQ, UK.

Lesley Jones (L)

Medical Research Council Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, CF24 4HQ, UK.

Sarah J Tabrizi (SJ)

UCL Huntington's Disease Centre,Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London,Queen Square, London WC1N 3BG, UK.
UK Dementia Research Institute, University College London, WC1N 3BG, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH